The American Journal of Health Economics articles examine policies to address opioid crisis

FHS
July 11, 2023
12:04 am

The August 2023 issue of the American Journal of Health Economics will feature a cluster of articles that examine the opioid crisis.

Novartis expands Scemblix label to first-line CML patients

Novartis’ chronic myeloid leukemia drug Scemblix will now be available to newly diagnosed patients, the FDA announced on Tuesday. Scemblix was first approved in 2021

October 30, 2024

annual financial statements 2023 characterized by the difficult economic environment and restructuring measures introduced, good operational progress – Biotech Investments

EQS-News: aap Implantate AG / Key word(s): Annual Report aap Implantate AG: annual financial statements 2023 characterized by the difficult economic environment and restructuring measures

August 24, 2024

Awakn Life Sciences Announces Launch of Licensing Partnership Agreement with Oklahoma Based Clinic | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – April 3, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.